当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:47.09亿  总市值:48.87亿
流通股本:3.70亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.62亿元,每股收益0.40元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益376202.45万元,未分配利润87550.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产560393.99万元,负债184191.54万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,515,318,391.161,758,578,253.52931,696,552.763,538,312,459.65
营业总成本2,333,206,417.211,604,450,464.21824,597,996.183,293,667,808.57
营业利润195,266,352.27162,771,273.34115,649,572.17225,849,216.89
利润总额196,941,619.51163,999,839.88115,554,756.31225,407,539.95
净利润162,100,822.21138,962,484.8389,158,928.05193,310,999.11
其他综合收益---1,705,202.58
综合收益总额162,100,822.21138,962,484.8389,158,928.05195,016,201.69
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,211,713,748.212,303,004,174.632,370,818,641.242,369,280,812.57
非流动资产合计3,392,226,128.673,434,801,957.193,529,685,124.533,546,798,516.24
资产总计5,603,939,876.885,737,806,131.825,900,503,765.775,916,079,328.81
流动负债合计1,339,988,545.731,428,847,510.691,510,537,434.681,600,325,890.83
非流动负债合计501,926,879.36513,464,407.93571,032,281.54534,693,997.24
负债合计1,841,915,425.091,942,311,918.622,081,569,716.222,135,019,888.07
归属于母公司股东权益合计3,699,709,849.543,716,657,502.283,744,616,592.633,714,133,643.74
股东权益合计3,762,024,451.793,795,494,213.23,818,934,049.553,781,059,440.74
负债和股东权益合计5,603,939,876.885,737,806,131.825,900,503,765.775,916,079,328.81
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,316,827,573.741,664,940,444.24908,762,226.033,330,709,544.09
经营活动现金流出小计2,115,388,750.921,489,989,131.7867,389,029.392,666,634,411.28
经营活动产生的现金流量净额201,438,822.82174,951,312.5441,373,196.64664,075,132.81
投资活动现金流入小计249,565,290.53166,781,815.1996,694,101187,148,157.2
投资活动现金流出小计356,475,243.27190,517,775.45148,109,225.66497,136,919.57
投资活动产生的现金流量净额-106,909,952.74-23,735,960.26-51,415,124.66-309,988,762.37
筹资活动现金流入小计193,540,000192,540,000190,000,000348,368,315.6
筹资活动现金流出小计349,159,037.29282,356,089.74164,248,733.14591,679,151.28
筹资活动产生的现金流量净额-155,619,037.29-89,816,089.7425,751,266.86-243,310,835.68
汇率变动对现金及现金等价物的影响4,242,300.793,885,201.351,270,711.153,466,169.14
现金及现金等价物净增加额-56,847,866.4265,284,463.8916,980,049.99114,241,703.9
期末现金及现金等价物余额847,173,261.89969,305,592.2921,001,178.3904,021,128.31
TOP↑